Reuters logo
BRIEF-Juno Therapeutics reports Q1 loss per share $0.79
May 4, 2017 / 8:24 PM / 5 months ago

BRIEF-Juno Therapeutics reports Q1 loss per share $0.79

May 4 (Reuters) - Juno Therapeutics Inc

* Juno Therapeutics reports first quarter 2017 financial results

* Q1 loss per share $0.79

* Juno Therapeutics Inc - Revenue for three months ended March 31, 2017 and 2016 was $19.3 million and $9.8 million

* Q1 earnings per share view $-0.71 -- Thomson Reuters I/B/E/S

* Juno Therapeutics Inc - Reaffirms 2017 cash burn of between $270 million and $300 million

* Juno Therapeutics Inc - Capital expenditures, net of tenant improvement allowances, estimated to be between $22 million and $27 million for FY Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below